Study to Evaluate the Safety of Intravitreal APL-2 in Patients Diagnosed With Geographic Atrophy

NCT03777332 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
19
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Apellis Pharmaceuticals, Inc.